Phrontline

About

Phrontline Biopharma is dedicated to developing innovative antibody-drug conjugates (ADCs) to address unmet medical needs in oncology. We specialize in engineering dual-targeting antibodies to enhance the precision and efficiency of payload delivery. In parallel, our proprietary dual-payload platforms are designed to overcome drug resistance and extend treatment response, inspired by the clinical success of combination chemotherapy.